1887
Preview this article:

There is no abstract available.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/00222615-39-4-243
1993-10-01
2023-01-31
Loading full text...

Full text loading...

/deliver/fulltext/jmm/39/4/medmicro-39-4-243.html?itemId=/content/journal/jmm/10.1099/00222615-39-4-243&mimeType=html&fmt=ahah

References

  1. Simpson LC. The origin, structure and pharmacological activity of botulinum toxin. Pharmacol Rev 1981; 33:155–188
    [Google Scholar]
  2. Tacket CO, Ragowski MA. Botulism. In: Simpson LC. (ed) Botulinum neurotoxin and tetanus toxin New York: Academic Press; 1989351–378
    [Google Scholar]
  3. MacDonald KL, Cohen ML, Blake PA. The changing epidemiology of adult botulism in the United States. Am J Epidemiol 1986; 124:794–799
    [Google Scholar]
  4. MacDonald KL, Rutherford GW, Friedman SM et al. Botulism and botulism-like illness in chronic drug abusers. Ann Intern Med 1985; 102:616–618
    [Google Scholar]
  5. Stephen J, Pietrowski RA. Bacterial toxins. Walton-on-Thames, Nelson; 19811–8
    [Google Scholar]
  6. Arnon SS. Infant botulism. In: Boriello SP. (ed) Clinical and molecular aspects of anaerobes Petersfield: Wrightson Biomedical Publishing Ltd.; 199041–48
    [Google Scholar]
  7. Burgen ASV, Dickens F, Zatman LJ. The action of botulinum toxin on the neuromuscular junction. J Phvsiol 1949; 109:10–24
    [Google Scholar]
  8. Shone CC, Hambleton P. Toxigenic Clostridia. In: Minton NP, Clarke DJ. (eds) Clostridia New York: Plenum Press; 1989265–292
    [Google Scholar]
  9. Niemann H. Molecular biology of clostridial neurotoxins. In: Sourcebook of bacterial protein toxins London: Academic Press; 1991303–348
    [Google Scholar]
  10. Harris AJ, Miledi R. The effect of type D botulinum toxin on frog neuromuscular junctions. J Physiol 1971; 217:497–515
    [Google Scholar]
  11. Dreyer F, Mallart A, Brigant JL. Botulinum A toxin and tetanus toxin do not affect presynaptic membrane currents in mammalian motor nerve endings. Brain Res 1983; 270:373–375
    [Google Scholar]
  12. Dolly JO, Black J, Williams RS, Melling J. Acceptors for botulinum neurotoxin reside on motor nerve terminals and mediate its internalisation. Nature 1984; 307:457–460
    [Google Scholar]
  13. Simpson LC. Peripheral actions of the botulinum toxins. In: Simpson LC. (ed) Botulinum neurotoxin and tetanus toxin New York: Academic Press; 1989153–178
    [Google Scholar]
  14. de Paiva A, Dolly JO. Light chain of botulinum neurotoxin is active in mammalian nerve terminals when delivered via liposomes. FEBS Lett 1990; 277:171–174
    [Google Scholar]
  15. Shone CC, Hambleton P, Melling J. Inactivation of Clostridium botulinum type A neurotoxin by trypsin and purification of two tryptic fragments. Proteolytic action near the COOH-terminus of the heavy subunit destroys toxin-binding activity. Eur JBiochem 1985; 151:75–82
    [Google Scholar]
  16. Kozaki S, Ogasawara J, Shimote Y, Kamata Y, Sakaguchi G. Antigenic structure of Clostridium botulinum type B neurotoxin and its interaction with gangliosides, cerebrosides and free fatty acids. Infect Immun 1987; 55:3051–3056
    [Google Scholar]
  17. Shone CC, Hambleton P, Melling J. A 50-kDa fragment from the NH2-terminus of the heavy subunit of Clostridium botulinum type A neurotoxin forms channels in lipid vesicles. Eur J Biochem 1987; 167:175–180
    [Google Scholar]
  18. Schiavo G, Rossetto O, Santucci A, DasGupta BR, Montecucco C. Botulinum neurotoxins are zinc proteins. J Biol Chem 1992; 267:23479–23483
    [Google Scholar]
  19. Schiavo G, Benfenati F, Poulain B et al. Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin. Nature 1992; 359:832–835
    [Google Scholar]
  20. Scott AB. Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery. Ophthalmology 1980; 87:1044–1049
    [Google Scholar]
  21. Marsden CD, Quinn NP. The dystonias Neurological disorders affecting 20 000 people in Britain. BMJ 1990; 300:139–144
    [Google Scholar]
  22. Jankovic J, Brin MF. Therapeutic uses of botulinum toxin. New Engl J Med 1991; 324:1186–1194
    [Google Scholar]
  23. Elston JS. Botulinum toxin treatment of blepharospasm. Adv Neurol 1988; 50:579–581
    [Google Scholar]
  24. Tsui JKC, Eisen A, Stoessl AJ, Caine S, Caine DB. Double blind study of botulinum toxin in spasmodic torticollis. Neurology 1986; 40:1213–1218
    [Google Scholar]
  25. Hambleton P, Cohen HE, Palmer BJ, Melling J. Antitoxins and botulinum toxin treatment. BMJ 1992; 304:959–960
    [Google Scholar]
  26. Ludlow CL, Hallet M, Rhew K et al. Therapeutic use of type F botulinum toxin. N Engl J Med 1992; 326:349–350
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/00222615-39-4-243
Loading

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error